home / stock / pdsb / pdsb short
Short Information | PDS Biotechnology Corporation (NYSE:PDSB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 111,905 |
Total Actual Volume | 2,531,394 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 5,595 |
Average Short Percentage | 5.70% |
Is there a PDSB Short Squeeze or Breakout about to happen?
See the PDSB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $1.30 | $1.32 | $1.36 | $1.29 | 1,249,860 | 31,693 | 2.54% |
02-11-2020 | $2.04 | $1.78 | $2.05 | $1.72 | 190,399 | 16,563 | 8.7% |
02-10-2020 | $2.4001 | $2.03 | $2.445 | $2.03 | 141,998 | 10,450 | 7.36% |
02-07-2020 | $2.66 | $2.28 | $2.66 | $2.22 | 143,894 | 11,889 | 8.26% |
02-06-2020 | $2.32 | $2.64 | $2.70 | $2.21 | 69,111 | 1,532 | 2.22% |
02-05-2020 | $2.56 | $2.31 | $2.60 | $2.11 | 130,641 | 8,176 | 6.26% |
02-04-2020 | $2.5197 | $2.52 | $2.59 | $2.402 | 15,181 | 240 | 1.58% |
02-03-2020 | $2.33 | $2.47 | $2.57 | $2.33 | 15,059 | 986 | 6.55% |
01-31-2020 | $2.50 | $2.47 | $2.64 | $2.38 | 69,090 | 3,172 | 4.59% |
01-30-2020 | $2.56 | $2.62 | $2.65 | $2.41 | 38,055 | 1,960 | 5.15% |
01-29-2020 | $2.6855 | $2.5528 | $2.70 | $2.455 | 47,121 | 1,517 | 3.22% |
01-28-2020 | $3.00 | $2.61 | $3.01 | $2.61 | 97,131 | 3,024 | 3.11% |
01-27-2020 | $2.62 | $2.85 | $2.95 | $2.62 | 95,319 | 2,122 | 2.23% |
01-24-2020 | $3.10 | $2.77 | $3.10 | $2.64 | 40,947 | 6,694 | 16.35% |
01-23-2020 | $2.60 | $3.03 | $3.03 | $2.45 | 36,762 | 2,042 | 5.55% |
01-22-2020 | $2.30 | $2.64 | $2.701 | $2.30 | 33,278 | 8,843 | 26.57% |
01-21-2020 | $2.51 | $2.36 | $2.58 | $2.33 | 19,293 | 577 | 2.99% |
01-17-2020 | $2.51 | $2.54 | $2.6381 | $2.51 | 20,206 | 1 | 0% |
01-16-2020 | $2.52 | $2.50 | $2.64 | $2.35 | 14,344 | 4 | 0.03% |
01-15-2020 | $2.735 | $2.44 | $2.735 | $2.34 | 63,705 | 420 | 0.66% |
News, Short Squeeze, Breakout and More Instantly...
PDS Biotechnology Corporation Company Name:
PDSB Stock Symbol:
NYSE Market:
PDS Biotechnology Corporation Website:
Company to Host Key Opinion Leader Event on May 8 at 1:30pm ET to Discuss Updated Results of VERSATILE-002, Unmet Treatment Needs in Advanced Head and Neck Cancer and planned Triple Combination Trial PRINCETON, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq...
Unique mechanism of action of the combination of PDS01ADC and Versamune ® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to focus late-stage clinical strategy on triple combination of PDS01ADC,...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...